Holger Weishaupt
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Journal: Cancer research
Published: June 28, 2022
Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas.
Journal: Neuro-oncology
Published: June 23, 2022
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Journal: Nature communications
Published: March 25, 2022
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 05, 2020
Perturbation-based gene regulatory network inference to unravel oncogenic mechanisms.
Journal: Scientific reports
Published: October 26, 2019
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells.
Journal: Cell death & disease
Published: July 18, 2019
Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes.
Journal: Bioinformatics (Oxford, England)
Published: March 26, 2018
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
Journal: Oncogene
Published: June 13, 2017
Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic Potential.
Journal: Frontiers in oncology
Published: April 12, 2017
Last Updated: 09/26/2026